Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2026-01-05 @ 5:48 PM
Study NCT ID:
NCT03276156
Status:
UNKNOWN
Last Update Posted:
2017-09-08
First Post:
2017-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer
Sponsor:
Zhejiang Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-23
Start Date Type:
ACTUAL
Primary Completion Date:
2018-02-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-02-22
Completion Date Type:
ESTIMATED
First Submit Date:
2017-09-06
First Submit QC Date:
None
Study First Post Date:
2017-09-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-09-06
Last Update Post Date:
2017-09-08
Last Update Post Date Type:
ACTUAL